Genmab

This is the limited version of the Genmab company profile: Join LinkedIn or Sign In to see more information.

Current Company Logo

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Genmab's world class discovery, development and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs. Our primary goal is to improve the lives of patients who are in urgent need of new treatment options.

Specialties

antibodies

Your Connections to Genmab

To see how you’re connected: Join Now or Sign In

Popular Profiles at Genmab

New Hires and Recent Promotions at Genmab

  • Martin Sahlin, Outsourcing & Contract Manager

    was Project Manager, Aseptic Processing - last month

  • Anette Østergaard, Director, Clinical Development

    was Associate Director, Clinical Development - 5 months ago

  • Miranda Molenaar, Associate Director, New Products

    was Assistant Director, New Products - 5 months ago

  • Martin Schultz, International Clinical Project Leader

    was Senior International Clinical Trial Manager - 5 months ago

  • Peter Hjorth, Senior Regulatory Safety Manager

    was Regulatory Safety Manager - 5 months ago

To see more new hires & promotions: Join Now or Sign In

Last edited by Quality Assurance Associate at Genmab B.V.

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.

This LinkedIn Company Profile was created by LinkedIn and is about Genmab. This page is not endorsed by or affiliated with Genmab. For questions regarding LinkedIn Company Profiles, contact us.

Genmab (GEN) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions